CARILLON TOWER ADVISERS, INC. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,359,000
+4.3%
72,136
-4.9%
0.02%
-53.5%
Q3 2020$3,222,000
+33.5%
75,836
+50.8%
0.04%
+126.3%
Q2 2020$2,413,000
-99.9%
50,296
-2.3%
0.02%
-17.4%
Q1 2020$2,369,000,000
-30.8%
51,496
-9.6%
0.02%0.0%
Q4 2019$3,424,000,000
+102661.1%
56,996
-3.2%
0.02%0.0%
Q3 2019$3,332,000
+0.8%
58,896
-0.8%
0.02%0.0%
Q2 2019$3,307,000
+22.4%
59,396
+11.0%
0.02%
+21.1%
Q1 2019$2,701,000
+26.0%
53,496
+0.6%
0.02%
+5.6%
Q4 2018$2,143,000
-27.3%
53,196
+25.2%
0.02%
-14.3%
Q3 2018$2,946,00042,4960.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders